PHARMATHENE, INC 4
4 · PHARMATHENE, INC · Filed Jan 24, 2017
Insider Transaction Report
Form 4
Runge Jeffrey W.
Director
Transactions
- Exercise/Conversion
Common Stock, par value $0.0001 per share
2017-01-20$3.11/sh+20,000$62,200→ 197,700 total - Exercise/Conversion
Stock Option (right to buy)
2017-01-20−20,000→ 0 totalExercise: $3.11From: 2012-06-23Exp: 2021-06-23→ Common Stock (20,000 underlying)